Last update 01 Nov 2024
Zonsen Peplib Biotech Co., Ltd.

Zonsen Peplib Biotech Co., Ltd.

Startups
|
Holding Company|
2017|
Hunan Sheng, China
|
< 10
|
peplib.cn

Overview

Tags

Neoplasms
Endocrinology and Metabolic Disease
Digestive System Disorders
Recombinant polypeptide
Peptide Conjugate Radionuclide
Synthetic peptide

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms13
Endocrinology and Metabolic Disease5
Nervous System Diseases4
Infectious Diseases2
Immune System Diseases2
Top 5 Drug TypeCount
Recombinant polypeptide12
Peptide Conjugate Radionuclide10
Synthetic peptide8
Peptide drug conjugates1
Radiopharmaceuticals and diagnostic agent1
Top 5 TargetCount
PSD95(Disks large homolog 4)2
MC3R(Melanocortin receptor 3)2
nectin-42
TNFRSF14(TNF receptor superfamily member 14)1
NPFFR2(neuropeptide FF receptor 2)1

Related

32
Drugs associated with Zonsen Peplib Biotech Co., Ltd.
PL-053
Target
CYP27A1
Mechanism
CYP27A1 modulators
Active Org.
Zonsen Peplib Biotech Co., Ltd.Zonsen Peplib Biotech Co., Ltd.Startup
Originator Org.
Zonsen Peplib Biotech Co., Ltd.Zonsen Peplib Biotech Co., Ltd.Startup
Active Indication
Glioma
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
PL-054
Target
CD14 x LPS
Mechanism
CD14 inhibitors [+1]
Active Org.
Hunan Jiudian Pharmaceutical Co., Ltd.Hunan Jiudian Pharmaceutical Co., Ltd. [+1]
Originator Org.
Zonsen Peplib Biotech Co., Ltd.Zonsen Peplib Biotech Co., Ltd.Startup
Active Indication
Bacterial Infections [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
23-R09(GPC3)
Target
GPC3
Mechanism
GPC3 modulators
Active Org.
Zonsen Peplib Biotech Co., Ltd.Zonsen Peplib Biotech Co., Ltd.Startup
Originator Org.
Zonsen Peplib Biotech Co., Ltd.Zonsen Peplib Biotech Co., Ltd.Startup
Active Indication
Hepatocellular Carcinoma
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Zonsen Peplib Biotech Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Zonsen Peplib Biotech Co., Ltd.
Login to view more data
100 Deals associated with Zonsen Peplib Biotech Co., Ltd.
Login to view more data
100 Translational Medicine associated with Zonsen Peplib Biotech Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
24
7
Preclinical
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
23-R09(FAP)
 ( FAP )		Gastrointestinal Neoplasms
More
Preclinical
PL-051
 ( GRPR )		Pancreatic Cancer
More
Preclinical
23-R09(GPC3)
 ( GPC3 )		Hepatocellular Carcinoma
More
Preclinical
PL-054
 ( CD14 x LPS )		Bacterial Infections
More
Preclinical
PL-053
 ( CYP27A1 )		Glioma
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free